MapLight Therapeutics (MPLT) Shares Outstanding (2024 - 2026)
MapLight Therapeutics (MPLT) posted Shares Outstanding (Entity) of $8.7 million for Q4 2025, up 974.33% sequentially from $808015.0 in Q3 2025, and up 1040.29% YoY from $761276.0 in Q4 2024.
Powered by 
Analysis
MapLight Therapeutics (MPLT) Shares Outstanding (2024 - 2026) Analysis & Trends
MapLight Therapeutics has reported Shares Outstanding (Entity) for 2 years, with the latest figure at $8.7 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 1040.29% year-over-year to $8.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.7 million (up 1040.29% YoY) and the FY2025 annual result came in at $8.7 million, up 1040.29% from the prior year.
- Shares Outstanding (Entity) rose to $8.7 million in Q4 2025 per MPLT's latest filing, from $808015.0 in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $8.7 million in Q4 2025 and troughed at $758795.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 61.30 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 111.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 445.06 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 217.35 Mn |
| 10 | MapLight Therapeutics | 631.50 Mn | 631.50 Mn | - | 45.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.43 Mn |
| Dec 31, 2025 | 8.68 Mn |
| Sep 30, 2025 | 791,127.00 |
| Jun 30, 2025 | 763,044.00 |
| Dec 31, 2024 | 736,178.00 |
| Sep 30, 2024 | 758,204.00 |